Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
Oraal vancomycine ter preventie van 'Clostridioides difficile'-infectie
okt 2020 | Antibioticaresistentie, Bacteriële infecties